Related references
Note: Only part of the references are listed.Current scenario of indole derivatives with potential anti-drug-resistant cancer activity
Yanshu Jia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structural Basis for Targeting T:T Mismatch with Triaminotriazine-Acridine Conjugate Induces a U-Shaped Head-to-Head Four-Way Junction in CTG Repeat DNA
Ching-Ming Chien et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia et al.
CANCER TREATMENT REVIEWS (2020)
Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy
Amit Kumar Rajora et al.
PHARMACEUTICS (2020)
Quinolone hybrids and their anti-cancer activities: An overview
Feng Gao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1-a]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links
Sue-Ming Chang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Threatening cancer with nanoparticle aided combination oncotherapy
Shruti Rawal et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Chemical Intuition in Drug Design and Discovery
Julia G. B. Pedreira et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview
Khurshed Bozorov et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review
Jaiprakash Sangshetti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Targeting Angiogenesis in Colorectal Carcinoma
Anthony Lopez et al.
DRUGS (2019)
Progress in the treatment of solid tumors with apatinib: a systematic review
Deze Zhao et al.
ONCOTARGETS AND THERAPY (2018)
A Low-Toxicity DNA-Alkylating N-Mustard-Quinoline Conjugate with Preferential Sequence Specificity Exerts Potent Antitumor Activity Against Colorectal Cancer
Tai-Lin Chen et al.
NEOPLASIA (2018)
An overview of benzo[b]thiophene-based medicinal chemistry
Rangappa S. Keri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
Vera Loizzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer A Systematic Review and Pooled Analysis
Gianluca Tomasello et al.
JAMA ONCOLOGY (2017)
Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR-2 Inhibitors
Abdel-Ghany A. El-Helby et al.
ARCHIV DER PHARMAZIE (2017)
Hybrid Compounds as Multitarget Directed Anticancer Agents
Ertan Kucuksayan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Identification of new potent phthalazine derivatives with VEGFR-2 and EGFR kinase inhibitory activity
Kamilia M. Amin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl) phthalazine derivatives
Wagdy M. Eldehna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation
Sahar M. Abou-Seri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
An overview of molecular hybrids in drug discovery
Gervais Berube
EXPERT OPINION ON DRUG DISCOVERY (2016)
A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells
Chi-Wei Chen et al.
NEOPLASIA (2016)
Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Assunta Sgambato et al.
CURRENT DRUG SAFETY (2016)
Phthalazin-1(2H)-one as a remarkable scaffold in drug discovery
Noemi Vila et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Imidazole-containing phthalazine derivatives inhibit Fe-SOD performance in Leishmania species and are active in vitro against visceral and mucosal leishmaniasis
M. Sanchez-Moreno et al.
PARASITOLOGY (2015)
Tumour Angiogenesis and Angiogenic Inhibitors: A Review
Lalita Yadav et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2015)
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Naveen S. Vasudev et al.
ANGIOGENESIS (2014)
The synthesis and biological evaluation of new DNA-directed alkylating agents, phenyl N-mustard-4-anilinoquinoline conjugates containing a urea linker
Bhavin Marvania et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Molecular-targeted agents combination therapy for cancer: Developments and potentials
Feifei Li et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
The development of bis(hydroxymethyl)pyrrole analogs as bifunctional DNA cross-linking agents and their chemotherapeutic potential
Tsann-Long Su et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein
Yu-Sheng Lo et al.
FEBS LETTERS (2013)
Novel Antitumor Indolizino[6,7-b]indoles with Multiple Modes of Action: DNA Cross-Linking and Topoisomerase I and II Inhibition
Ravi Chaniyara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis and antitumor evaluation of novel Benzo[d]pyrrolo[2,1-b]thiazole derivatives
Ravi Chaniyara et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
THE STRUCTURES OF 8-AND 10-TRIFLUOROMETHYLQUINO[3,2-b]BENZO[1,4]THIAZINES AND THEIR BENZYL DERIVATIVES
Malgorzata Jelen et al.
HETEROCYCLES (2012)
Novel bifunctional alkylating agents, 5,10-dihydropyrrolo[1,2-b]isoquinoline derivatives, synthesis and biological activity
Ravi Chaniyara et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
How well do medicinal chemists learn from experience?
David R. Cheshire
DRUG DISCOVERY TODAY (2011)
In Vivo Trypanosomicidal Activity of Imidazole- or Pyrazole-Based Benzo[g]phthalazine Derivatives against Acute and Chronic Phases of Chagas Disease
Manuel Sanchez-Moreno et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Syntheses of 2,3-Diarylated 2H-Benzo[e][1,2]Thiazine 1,1-Dioxides and their 3,4-Dihydro Derivatives, and Assessment of their Inhibitory Activity Against MCF-7 Breast Cancer Cells
Yuan-Yuan Shan et al.
MEDICINAL CHEMISTRY (2011)
Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
Vince D. Cataldo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Combination of Bifunctional Alkylating Agent and Arsenic Trioxide Synergistically Suppresses the Growth of Drug-Resistant Tumor Cells
Pei-Chih Lee et al.
NEOPLASIA (2010)
Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2
Matthew A. J. Duncton et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes
Rajesh Kakadiya et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Robert Roskoski
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group
F Fossella et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay
L Guedez et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Alkylation of guanine in DNA by S23906-1, a novel potent antitumor compound derived from the plant alkaloid acronycine
MH David-Cordonnier et al.
BIOCHEMISTRY (2002)
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis
G Bold et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3,2-h]acridin-7-one analogues of acronycine
N Costes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
